Cargando…

Antitumor Research on Artemisinin and Its Bioactive Derivatives

ABSTRACT: Cancer is the leading cause of human death which seriously threatens human life. The antimalarial drug artemisinin and its derivatives have been discovered with considerable anticancer properties. Simultaneously, a variety of target-selective artemisinin-related compounds with high efficie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yunqin, Xu, Guowei, Zhang, Shuqun, Wang, Dong, Saravana Prabha, P., Zuo, Zhili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102173/
https://www.ncbi.nlm.nih.gov/pubmed/29633188
http://dx.doi.org/10.1007/s13659-018-0162-1
_version_ 1783349104260153344
author Zhang, Yunqin
Xu, Guowei
Zhang, Shuqun
Wang, Dong
Saravana Prabha, P.
Zuo, Zhili
author_facet Zhang, Yunqin
Xu, Guowei
Zhang, Shuqun
Wang, Dong
Saravana Prabha, P.
Zuo, Zhili
author_sort Zhang, Yunqin
collection PubMed
description ABSTRACT: Cancer is the leading cause of human death which seriously threatens human life. The antimalarial drug artemisinin and its derivatives have been discovered with considerable anticancer properties. Simultaneously, a variety of target-selective artemisinin-related compounds with high efficiency have been discovered. Many researches indicated that artemisinin-related compounds have cytotoxic effects against a variety of cancer cells through pleiotropic effects, including inhibiting the proliferation of tumor cells, promoting apoptosis, inducing cell cycle arrest, disrupting cancer invasion and metastasis, preventing angiogenesis, mediating the tumor-related signaling pathways, and regulating tumor microenvironment. More importantly, artemisinins demonstrated minor side effects to normal cells and manifested the ability to overcome multidrug-resistance which is widely observed in cancer patients. Therefore, we concentrated on the new advances and development of artemisinin and its derivatives as potential antitumor agents in recent 5 years. It is our hope that this review could be helpful for further exploration of novel artemisinin-related antitumor agents. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-6102173
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-61021732018-08-27 Antitumor Research on Artemisinin and Its Bioactive Derivatives Zhang, Yunqin Xu, Guowei Zhang, Shuqun Wang, Dong Saravana Prabha, P. Zuo, Zhili Nat Prod Bioprospect Review ABSTRACT: Cancer is the leading cause of human death which seriously threatens human life. The antimalarial drug artemisinin and its derivatives have been discovered with considerable anticancer properties. Simultaneously, a variety of target-selective artemisinin-related compounds with high efficiency have been discovered. Many researches indicated that artemisinin-related compounds have cytotoxic effects against a variety of cancer cells through pleiotropic effects, including inhibiting the proliferation of tumor cells, promoting apoptosis, inducing cell cycle arrest, disrupting cancer invasion and metastasis, preventing angiogenesis, mediating the tumor-related signaling pathways, and regulating tumor microenvironment. More importantly, artemisinins demonstrated minor side effects to normal cells and manifested the ability to overcome multidrug-resistance which is widely observed in cancer patients. Therefore, we concentrated on the new advances and development of artemisinin and its derivatives as potential antitumor agents in recent 5 years. It is our hope that this review could be helpful for further exploration of novel artemisinin-related antitumor agents. GRAPHICAL ABSTRACT: [Image: see text] Springer Singapore 2018-04-09 /pmc/articles/PMC6102173/ /pubmed/29633188 http://dx.doi.org/10.1007/s13659-018-0162-1 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Zhang, Yunqin
Xu, Guowei
Zhang, Shuqun
Wang, Dong
Saravana Prabha, P.
Zuo, Zhili
Antitumor Research on Artemisinin and Its Bioactive Derivatives
title Antitumor Research on Artemisinin and Its Bioactive Derivatives
title_full Antitumor Research on Artemisinin and Its Bioactive Derivatives
title_fullStr Antitumor Research on Artemisinin and Its Bioactive Derivatives
title_full_unstemmed Antitumor Research on Artemisinin and Its Bioactive Derivatives
title_short Antitumor Research on Artemisinin and Its Bioactive Derivatives
title_sort antitumor research on artemisinin and its bioactive derivatives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102173/
https://www.ncbi.nlm.nih.gov/pubmed/29633188
http://dx.doi.org/10.1007/s13659-018-0162-1
work_keys_str_mv AT zhangyunqin antitumorresearchonartemisininanditsbioactivederivatives
AT xuguowei antitumorresearchonartemisininanditsbioactivederivatives
AT zhangshuqun antitumorresearchonartemisininanditsbioactivederivatives
AT wangdong antitumorresearchonartemisininanditsbioactivederivatives
AT saravanaprabhap antitumorresearchonartemisininanditsbioactivederivatives
AT zuozhili antitumorresearchonartemisininanditsbioactivederivatives